Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis
Clinical trial NCT02563899 · COMPLETED
Trial details
- NCT number
- NCT02563899
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-23
- Primary completion
- 2016-02-25
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.